Lee, Kyungwoo
Choi, Yonghyun
Kim, Namju
Lee, Hee-Young
Choi, Jonghoon https://orcid.org/0000-0003-3554-7033
Funding for this research was provided by:
Chung-Ang University (Chung-Ang University Research Scholarship Grants in 2022)
Article History
Received: 17 December 2023
Revised: 23 February 2024
Accepted: 6 March 2024
First Online: 31 March 2024
Declarations
:
: Dr. Jonghoon Choi is the CEO/Founder, and Dr. Yonghyun Choi is the CTO of the Feynman Institute of Technology at the Nanomedicine Corporation, Seoul, 06974, South Korea.